Statistics for Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Total visits
| views | |
|---|---|
| Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial | 3 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 3 |
File Visits
| views | |
|---|---|
| BarrosoSousa2022Cardiac-CCBY.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 2 |
| China | 1 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |
| Hangzhou | 1 |